Jan-Marcus Daniel

Jan-Marcus Daniel

Auto-generated profile, based on publicly available information

Jan-Marcus Daniel

University Hospital Halle, Martin‐Luther‐University Halle‐Wittenberg

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
JDJochen Dutzmann
Jochen Dutzmann
JDJan‐Marcus Daniel
Jan‐Marcus Daniel
LKLaura Korte
Laura Korte
FKFrederik J. Kloss
Frederik J. Kloss
KKKai Knöpp
Kai Knöpp
DSDaniel G. Sedding
Daniel G. Sedding
Background: Vascular restenosis resulting from neointima formation significantly limits the efficacy of percutaneous interventional therapies compared with bypass surgery. The adventitial layer is involved in neointima formation, but the detailed pathophysiological interplay of the different cell types in this process is still unclear. Methods: We analyzed the correlation between adventitial and neointimal tissue size in human postmortem restenotic lesions after angioplasty. In porcine and mouse models of vascular injury, we examined early proliferation of fibroblasts and adventitial expansion. Using anti‐CD45 antibodies, we identified recruited leukocytes as the source of fibroblast activation following vascular injury in mice. A time‐course experiment on neointima formation demonstrated that adventitial activation precedes the proliferation of medial and neointimal smooth muscle cells (SMCs). To further investigate this process, we developed a mouse model enabling the surgical removal and transplantation of adventitial tissue. Results: We observed that activated adventitial fibroblasts release interleukin 6 and other cytokines, which strongly induce SMC proliferation and migration in vitro. In interleukin 6 knockout mice, supernatants from activated adventitia grafts failed to stimulate SMC proliferation and migration. Furthermore, transplantation of adventitial grafts from interleukin 6 knockout mice did not induce neointima formation. Cell fate tracking experiments using double transgenic reporter mice demonstrated that resident adventitial cells do not directly contribute to the neointimal cellular mass. Instead, medial SMCs were identified as the primary source of neointimal cells. Conclusions: We show that the release of interleukin 6 by adventitial fibroblasts induces the subsequent proliferation and migration of medial SMC in the process of neointima formation. Thus, we propose a new paradigm for adventitial fibroblasts in this process as a paracrine inflammatory engine. Anti‐inflammatory targeting of the vascular adventitia might thus be promising to limit neointima formation.

1 August 2018 in European Heart Journal
Verified
Journal Article
Open access
PDF file
KKK Knoepp
K Knoepp
JDJ Dutzmann
J Dutzmann
KDK Donde
K Donde
LKL Korte
L Korte
JDJ M Daniel
J M Daniel
DSD Sedding
D Sedding
Background: Proliferation of vascular smooth muscle cells (VSMC) caused by stimulation of cytokines and growth factors plays a crucial role in the development of vascular proliferative diseases such as atherosclerosis and in-stent-restenosis after angioplasty. MicroRNAs (miR) are small noncoding RNAs that inhibit gene expression in a posttranscriptional manner and possibly contribute to the differential gene regulation that triggers vascular remodeling processes.

1 January 2024
Verified
Book Chapter
Closed access
PDF file
DSDaniel Sedding
Daniel Sedding
JDJan-Marcus Daniel
Jan-Marcus Daniel
UHUlrich Hofmann
Ulrich Hofmann